PATIENT INFORMATION HERE. Foundation Medicine, The Molecular Information Company, is connecting physicians and their patients to the latest cancer treatment approaches and making precision medicine a reality for thousands. Our portfolio of genomic tests is the leading platform for comprehensive genomic profiling.How are Foundation Medicine's genomic profiling services supported?
Our services are supported by a large and growing body of clinical evidence with over 500 publications since the founding of Foundation Medicine. 15-16 The validations of Foundation Medicine's comprehensive genomic profiling services are published in top-tier peer-reviewed journals. 4-7What is FoundationOne Liquid?
FoundationOne Liquid is the first and only liquid biopsy test to show prospective clinical utility in a global, registrational trial for patients with newly diagnosed, metastatic non-small cell lung cancer (NSCLC).What is FoundationOne CDx?
Overview What is FoundationOne CDx? FoundationOne CDx is the first FDA-approved tissue-based broad companion diagnostic (CDx) that is clinically and analytically validated for all solid tumors.